Name | Number of supported studies | Average coverage | |
---|---|---|---|
kidney loop of Henle epithelial cell | 7 studies | 34% ± 8% |
Insufficient scRNA-seq data for expression of CLDN16 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 79% | 47.49 | 518 / 653 | 79% | 94.93 | 476 / 605 |
liver | 94% | 59.26 | 212 / 226 | 34% | 1.38 | 138 / 406 |
kidney | 100% | 897.46 | 89 / 89 | 27% | 2.88 | 240 / 901 |
ovary | 24% | 6.57 | 43 / 180 | 91% | 127.29 | 392 / 430 |
uterus | 71% | 35.34 | 121 / 170 | 35% | 4.26 | 160 / 459 |
adrenal gland | 96% | 92.44 | 248 / 258 | 3% | 0.10 | 7 / 230 |
lung | 50% | 37.86 | 290 / 578 | 34% | 3.18 | 397 / 1155 |
skin | 74% | 128.34 | 1347 / 1809 | 4% | 0.20 | 17 / 472 |
pancreas | 53% | 16.25 | 175 / 328 | 21% | 0.89 | 37 / 178 |
brain | 67% | 27.58 | 1762 / 2642 | 0% | 0.00 | 1 / 705 |
prostate | 65% | 31.69 | 160 / 245 | 1% | 0.02 | 3 / 502 |
bladder | 43% | 27.33 | 9 / 21 | 21% | 1.88 | 106 / 504 |
esophagus | 30% | 10.29 | 428 / 1445 | 27% | 1.27 | 50 / 183 |
tonsil | 0% | 0 | 0 / 0 | 49% | 2.55 | 22 / 45 |
breast | 34% | 11.17 | 156 / 459 | 3% | 0.30 | 39 / 1118 |
adipose | 26% | 12.26 | 315 / 1204 | 0% | 0 | 0 / 0 |
stomach | 0% | 0.05 | 1 / 359 | 18% | 0.61 | 51 / 286 |
intestine | 3% | 1.25 | 26 / 966 | 13% | 0.43 | 70 / 527 |
lymph node | 0% | 0 | 0 / 0 | 10% | 2.64 | 3 / 29 |
peripheral blood | 6% | 2.69 | 59 / 929 | 0% | 0 | 0 / 0 |
spleen | 3% | 0.53 | 8 / 241 | 0% | 0 | 0 / 0 |
heart | 3% | 0.63 | 28 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 1% | 0.22 | 14 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030001 | Biological process | metal ion transport |
GO_0030003 | Biological process | intracellular monoatomic cation homeostasis |
GO_0010496 | Biological process | intercellular transport |
GO_0016338 | Biological process | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules |
GO_0007155 | Biological process | cell adhesion |
GO_0070830 | Biological process | bicellular tight junction assembly |
GO_1903830 | Biological process | magnesium ion transmembrane transport |
GO_0005886 | Cellular component | plasma membrane |
GO_0005923 | Cellular component | bicellular tight junction |
GO_0015095 | Molecular function | magnesium ion transmembrane transporter activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0005198 | Molecular function | structural molecule activity |
Gene name | CLDN16 |
Protein name | Claudin 16 Claudin-16 (Paracellin-1) (PCLN-1) |
Synonyms | PCLN1 |
Description | FUNCTION: Plays a major role in tight junction-specific obliteration of the intercellular space, through calcium-independent cell-adhesion activity. Involved in paracellular magnesium reabsorption. Required for a selective paracellular conductance. May form, alone or in partnership with other constituents, an intercellular pore permitting paracellular passage of magnesium and calcium ions down their electrochemical gradients. Alternatively, it could be a sensor of magnesium concentration that could alter paracellular permeability mediated by other factors. |
Accessions | ENST00000456423.2 ENST00000264734.3 Q9Y5I7 F6SGM4 |